GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)

United States Steel Revenue

GlaxoSmithKline Pharmaceuticals had revenue of 8.49B INR in the quarter ending June 30, 2025, with 4.20% growth. This brings the company's revenue in the last twelve months to 37.48B, up 6.88% year-over-year. In the fiscal year ending March 31, 2025, GlaxoSmithKline Pharmaceuticals had annual revenue of 37.49B with 8.56% growth.

• Revenue (ttm): 37.48B
• Revenue Growth: +6.88%
• P/S Ratio: 13.26
• Revenue / Employee: 12.04M
• Employees: 3,113
• Market Cap: 497.02B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	37.49B	2.96B	8.56%
Mar 31, 2024	34.54B	2.02B	6.21%
Mar 31, 2023	32.52B	-263.06M	-0.80%
Mar 31, 2022	32.78B	3.52B	12.05%
Mar 31, 2021	29.26B	-2.99B	-9.27%